LEMAITRE VASCULAR INC — Director's Dealing 2022

Dec 6, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2022-12-02

Reporting Person: Pellegrino Joseph P JR (Director, Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-02	Common Stock	M	4	—	Acquired	6112	Direct
2022-12-02	Common Stock	F	153	$47.17	Disposed	5959	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-12-02	Dividend Equivalent Rights	$0	M	4	Disposed		Common Stock (4)	Direct

Footnotes

F1: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

F2: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/2/2020. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.

F3: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/2/2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.